Specialist Infectious Disease Immunology Laboratory Solutions
Our Expertise
- Immunology assay development (immunogenicity, cytokine/biomarker profiling)
- Molecular assays (qPCR/ddPCR, NGS panels) and contamination screening
- Cell-based assays (neutralisation, infectivity, cytotoxicity)
- Microbiology (Operating at Containment Level 2 (CL2))
- Advanced sample handling and chain-of-custody with secure data integrity
- Programme support from pre-clinical through Phase III trials
Core Services
Infectious Disease Testing
Validated platforms for viral and bacterial targets with turnaround tailored to sponsor timelines.
Immunology & Biomarkers
Assay development and qualification for immunogenicity, cytokines and cellular responses.
Molecular & Genomics
qPCR/ddPCR for quantification: targeted NGS for variant detection and quality assurance.
Microbiology
Rapid setup and delivery of microbiological analyses, fully aligned with ICH Good Clinical Practice (GCP). Designed for high-throughput sample processing, we provide end-to-end support for bacterial challenge studies and microbiology-based research.
Cell Culture Lab
Our facility combines deep cell line expertise with robust technical capabilities, environmental monitoring, and secure access control to protect your work at every step.
Sample Handling Logistics
Controlled conditions, stability checks, and traceable audit trails across study phases.
Study Support (Pre‑clinical → Phase III)
Method development, validation summaries, and submission‑ready documentation.
From pre-clinical and translational work through to supporting large phase III studies our laboratories team are experienced from R&D through to tech transfer and operational delivery
Start ups
Early-stage start up biotechs are driving some of the most exciting innovation in therapeutics — but they also face unique barriers that slow progress, increase risk, and strain lean internal teams. Our start-up support model is built specifically to address these challenges, accelerate development, and help founders reach clinical and commercial milestones with confidence.
Regulatory Strategy as Competitive Advantage: From Compliance to Acceleration
For many years, regulatory affairs were viewed as a necessary hurdle in drug development. The role was to ensure compliance, prepare dossiers, and shepherd submissions through complex national and international frameworks. That perception is outdated. Today, regulatory strategy is not simply about compliance; it is a source of competitive advantage. When integrated early into drug development planning, regulatory expertise can accelerate timelines, de‑risk programmes, and even enhance the commercial value of a compound. At hVIVO, our regulatory experts have seen this transformation first‑hand. Their experience across early‑phase clinical trials, human challenge studies, and complex therapeutic areas has shown that regulatory affairs are no longer confined to the back room. They are central to shaping development pathways, influencing policy, and ensuring that innovative treatments reach patients more quickly.
Core Services
hVIVO is led by a dynamic group of experts in their respective fields who are driving excellence throughout the organisation.
Our Accreditations
Good Clinical Practice (GCP)
Good Clinical Practice (GCP) is an international ethical and scientific quality standard; for designing, conducting, recording and reporting trials. Ensuring participant safety prevails over the interests of science and society.

Human Tissue Authority (HTA)
hVIVO is accredited by the Human Tissue Authority (HTA), meaning that we have been recognized by the HTA as compliant with standards and regulations for the ethical and legal removal, storage, and use of human tissue. A HTA license is essential, as hVIVO handles human tissue for various research purposes.

Good Clinical Laboratory Practice (GCLP)
All clinical trials comply with GCP and/or GCP for Laboratories (GCLP) guidance. Human Challenge Agent-only clinical studies that do not involve IMP also comply with GCP/GCLP.

College of American Pathologists (CAP)
The CAP laboratory accreditation programme ultimately recognises laboratory quality and compliance. CAP accreditation is globally recognised, and provides assurance the hVIVO laboratory services are able to be delivered to a standard.

UKAS ISO/IEC 17025:2017 Accreditation

Yes. HVIVO laboratory solutions are designed to support sponsors across program phases.
Partner with hVIVO’s expert Laboratory Teams to deliver high-quality Clinical Data
Speak to our team about your study requirements.